Research Topics
| Marc ColonnaSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
[Cluster analysis in geographical epidemiology: the use of several statistical methods and comparison of their results]E Chirpaz
Registre des Cancers de l Isère, 21, chemin des Sources, 38240 Meylan
Rev Epidemiol Sante Publique 52:139-49. 2004..The objectives of this study were to compare several tests to detect disease clustering, among which modelisation using Markov Chain Monte Carlo methods...
Joint use of epidemiological and hospital medico-administrative data to estimate prevalence. Application to French data on breast cancerMarc Colonna
Registre des Cancers de l Isère, Grenoble, France
Cancer Epidemiol 36:116-21. 2012..Estimate complete, limited-duration, and hospital prevalence of breast cancer in a French Département covered by a population-based cancer registry and in whole France using complementary information sources...
Risk of cancer in the vicinity of municipal solid waste incinerators: importance of using a flexible modelling strategySarah Goria
Institute of Public Health Surveillance InVS, Saint Maurice, France
Int J Health Geogr 8:31. 2009..The aim of this paper is to show how important are advanced tools and statistical techniques to better assess weak associations between the risk of cancer and past environmental exposures...
Variation in relative survival of thyroid cancers in Europe: results from the analysis on 21 countries over the period 1983-1994 (EUROCARE-3 study)Marc Colonna
Isere Cancer Registry, 23 Chemin des Sources, 38240 Meylan, France
Eur J Cancer 42:2598-608. 2006..The only way to understand these differences is to conduct specific studies including a description of stage at diagnosis, diagnosis procedures used for staging and details of treatment...
Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012Marc Colonna
Network of French Cancer Registries FRANCIM, Toulouse, France
Eur J Cancer 44:115-22. 2008..This paper provides a prevalence estimate for 2002 and 2012 in France and an assessment of the trend in prevalence over the period 1993-2002...
[Influence of a priori parameters on bayesian relative risks estimations. Spatial distribution of bladder cancer in the urban area of Grenoble]M Colonna
Registre du Cancer de l Isère, 23, chemin des Sources, 38240 Meylan
Rev Epidemiol Sante Publique 54:529-42. 2006..We show that the risks can appear weak from a statistical point of view but important from an epidemiologic point of view in the presentation of the results...
A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000)M Colonna
FRANCIM, French Cancer Registries Network, Faculte de Medecine, 37 allée Jules Guesdes, 31073 Toulouse Cedex, France
Eur J Cancer 43:891-900. 2007..Obviously, these findings do not exclude the possible role of other factors...
Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983-2002Marc Colonna
Isere Cancer Registry, 23 Chemin des Sources, 38240 Meylan, France
Breast 17:289-92. 2008....
[Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005]M Colonna
Registre des Cancers de l Isère, 23, chemin des Sources, 38240 Meylan, France
Rev Epidemiol Sante Publique 56:434-40. 2008..Results on "all cancers" illustrate those comments...
[Descriptive analysis of trend of epidemiological observational data using JoinPoint: a user-friendly tool, seemingly]M Colonna
Registre du Cancer de l Isère, CHU de Grenoble, Grenoble, France
Rev Epidemiol Sante Publique 59:123-33. 2011..Analysis of the temporal trend of epidemiological data is becoming increasingly popular. For the purpose, the JoinPoint is a widely used software. We present important elements involved when using some of the options of this software...
Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: a study of five common cancersMarc Colonna
Isere Cancer Registry, Meylan, France
Int J Cancer 127:924-31. 2010....
Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survivalM Colonna
Registre du Cancer de l Isère, 23 Chemin des Sources, Meylan, France
Ann Endocrinol (Paris) 71:95-101. 2010..Describe time trends of incidence and mortality associated with thyroid cancer and provide 1 and 5-year survivals by histological group in French areas covered by cancer registries...
Unbiased estimates of long-term net survival of solid cancers in FranceValerie Jooste
FRANCIM French Network of Cancer Registries, Toulouse, France
Int J Cancer 132:2370-7. 2013..The 10-year net survival confirmed the persistent unfavorable role of age in prognosis and the general improvement of cancer management over the last decade...
A Suitable Approach to Estimate Cancer Incidence in Area without Cancer RegistryNicolas Mitton
Registre des Cancers de l Isère, 38240 Meylan, France
J Cancer Epidemiol 2011:418968. 2011..3 per 100.000 versus 5.2. Conclusion. Incidence estimation using PMSI patient identifiers proved encouraging though still dependent on the assumption of uniform cancer treatments and coding...
Incidence and mortality trends for prostate cancer in 5 French areas from 1982 to 1996Emmanuel Chirpaz
Registre des Cancers de l Isère, 21 Chemin des Sources, 38240 Meylan, France
Int J Cancer 97:372-6. 2002..Until results of randomized studies on mass screening are available, the question of individual screening remains; improved knowledge of risk factors could be interesting...
Bootstrap investigation of the stability of disease mapping of Bayesian cancer relative risk estimationsMarc Colonna
Isere Cancer Registry, 23 Chemin des Sources, 38240 Meylan, France
Eur J Epidemiol 19:761-8. 2004..As Bayesian approaches may induce very different estimations, it is useful to consider the stability of the estimations as a criterion for evaluating the quality of the results...
Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based studyCamille Cluze
Cancer Registry of Isère, Meylan, France
Eur J Cancer Prev 18:343-8. 2009..After prostate cancer, men had no greater risk of cancer, except for kidney cancer. Our results help to direct attention to regions especially vulnerable to secondary cancers after primary breast or colorectal cancer...
Determinants of participation in organized colorectal cancer screening in Isère (France)Florence Poncet
Registre du Cancer de l Isère, CHU de Grenoble, Pav E, BP 217, 38043 Grenoble Cedex 9, France Electronic address
Clin Res Hepatol Gastroenterol 37:193-9. 2013..In France, participation in organized colorectal cancer screening remains low. The objective of this study was to identify the determinants of participation in colorectal cancer screening in Isère, a French administrative entity...
Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry dataArnaud Seigneurin
Registre du Cancer de l Isère, Centre Hospitalier Universitaire de Grenoble, BP 217, Pavillon E, 38043 Grenoble Cedex 9, France
BMJ 343:d7017. 2011....
[Inframunicipality distribution of lung cancer in the urban area of Grenoble]A Senkowski
Laboratoire EPSP TIMC, Faculte de Medecine, Domaine de la Merci, 38700 La Tronche, France
Rev Epidemiol Sante Publique 56:315-21. 2008..Thus, our goal in this work was to use a new finer spatial scale to find out whether or not observed spatial variations might mask intramunicipality spatial variations...
The performance of multiple imputation for missing covariate data within the context of regression relative survival analysisRoch Giorgi
Laboratoire d Enseignement et de Recherche sur le Traitement de l Information Médicale, EA 3283, Faculte de Medecine, Universite de la Mediterranee, Marseille, France
Stat Med 27:6310-31. 2008..As illustration, we used data of the French Cancer Registries on relative survival of patients with colorectal cancer...
[Estimate of regional prevalence of colorectal cancer in France]M Colonna
Registre des Cancers de l Isère, 21, chemin des Sources, 38240 Meylan
Rev Epidemiol Sante Publique 50:243-51. 2002..Current estimations established from data for the years 1985 and 1995 can be used to establish a precise description of changing healthcare needs for colorectal cancer...
Analysis and classification of interval cancers in a French breast cancer screening programme (département of Isère)C Exbrayat
Registre du Cancer de l Isère, Meylan, France
Eur J Cancer Prev 8:255-60. 1999..Interval cancer rates are low during the first year. Higher rates for the second year and early stages of diagnosis could be explained by self-referred screening practice in our area...
Contacts with animals and humans as risk factors for adult brain tumours. An international case-control studyF Menegoz
Registre du Cancer de l Isère, 21 Chemin des Sources, 38240 Meylan, France
Eur J Cancer 38:696-704. 2002..With some exceptions, these results indicate no association between either the type of brain tumour and contacts with animals, or with occupations that include a high level of contact with animals or a high level of contact with humans...
Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997)M Colonna
Registre des Cancers de l Isère, 21 Chemin des Sources, 38240 Meylan, France
Eur J Cancer 38:1762-8. 2002..It may be attributed to a possible screening effect or to an increase in the number of "incidentally" discovered cases linked to the use of modern diagnostic tools...
A cohort study of workers exposed to chloroprene in the department of Isère, FranceM Colonna
Registre des Cancers de l Isère, 21 Chemin des Sources, 38240 Meylan, France
Chem Biol Interact 135:505-14. 2001..The variations in the excess of the risk of cancer of the lung, head and neck were hardly compatible with a professional risk factor...
Estimation of colorectal cancer prevalence in FranceM Colonna
Registre des Cancers de l Isère, 21 Chemin des Sources, 38240, Meylan, France
Eur J Cancer 37:93-6. 2001..This type of cancer is the most common in both men and women and these results enable the need for care or surveillance to be evaluated more accurately...
National cancer prevalence estimation in FranceM Colonna
Registre des Cancers de l Isère, Meylan, France
Int J Cancer 87:301-4. 2000..The most frequent cancer sites are head and neck, breast, and large bowel. Most of the cancer sites present an increase in prevalence proportion between 1987 and 1992. The larger increases concern breast and prostate cancer...
Comparison of interval breast cancer rates for two-versus single-view screening mammography: a population-based studyA Seigneurin
Registre du Cancer de l Isère, 23 Chemin des Sources, Meylan, France
Breast 18:284-8. 2009..To determine whether the implementation of two-view mammography was followed by a reduction in the rates of interval cancers...
Cancer incidence in a chlorochemical plant in Isère, France: an occupational cohort study, 1979-2002Vincent Bonneterre
Consultation de Pathologies Professionnelles et Environnementales, pôle de santé publique, CHU Grenoble, Grenoble Cedex, France
Am J Ind Med 55:756-67. 2012..A major French chlorine chemical plant (chlor-alkali process with diaphragm cell and manufacturing of organochlorine chemicals) has used or produced known or suspected carcinogenic compounds...
Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trialMichel Bolla
Department of Oncology Radiotherapy, Centre Hospitalier Universitaire, Grenoble, France
Radiother Oncol 97:312-7. 2010..We evaluate the feasibility of concomitant and adjuvant docetaxel combined with three-dimensional conformal radiotherapy (3D-CRT) and androgen deprivation in high-risk prostate carcinomas...
Analysis of the effect of age on the prognosis of breast cancerC Cluze
Cancer Registry of Isère, Meylan, France
Breast Cancer Res Treat 117:121-9. 2009..Our findings suggest that when taking into account grade and stage, the time-varying impact of young age at diagnosis is limited to grade 3 tumors, without evidence of worst prognosis at 5 years for the youngest women...
Prognostic assessment of PTK activity in T1-T2, N0-N1, M0 breast cancer: a multicentric retrospective studyBéatrice Rostaing-Puissant
Laboratoire de Biochimie A, CHU A Michallon, Grenoble, France
Breast Cancer Res Treat 74:135-41. 2002....
Measuring cancer prevalence in Europe: the EUROPREVAL projectR Capocaccia
Istituto Superiore di Sanita, Rome, Italy
Ann Oncol 13:831-9. 2002..Prevalence of cancer is estimated to be 2% on average, with the highest values (3%) in Sweden and the lowest in Eastern Europe, with a minimum of approximately 1% in Poland...
A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and SpainA Verdecchia
Istituto Superiore di Sanita, Rome, Italy
Ann Oncol 13:1128-39. 2002..This subset of the prevalent population consists of those probably on intensive follow-up, or being treated for cancer recurrence or sequelae to primary therapy...
[Course and prognosis of basaloid squamous cell carcinoma: case-control study of 49 patients]E Soriano
Service d'ORL, , CHU BP 217, 38043 Grenoble Cedex
Ann Otolaryngol Chir Cervicofac 122:173-80. 2005..We also recommend post-operative or exclusive radiotherapy which may be associated with concomitant chemotherapy...
[How to choose in practice a model to describe the geographic variation of cancer incidence? Example of gastrointestinal cancers from Côte-d'Or]S David
Service de Biostatistiques, Bât 1M, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
Rev Epidemiol Sante Publique 50:413-25. 2002....
Cancer incidence and mortality in France over the period 1978-2000L Remontet
Service de Biostatistique des Hospices Civils de Lyon, Batiment 1M, Centre Hospitalier Lyon-Sud, 165, chemin du Grand-Revoyet,
Rev Epidemiol Sante Publique 51:3-30. 2003..The trend of lung cancer mortality among women should be emphasised since the situation will inevitably worsen in the coming years. It is already the third cause of cancer death among women...
[Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroïd cancer (1999-2000)]N Carre
Département des maladies chroniques et traumatismes, Institut de Veille Sanitaire, InVS, 12, rue du Val d Osne, 94415 Saint Maurice
Rev Epidemiol Sante Publique 54:367-76. 2006..A nationwide database, such as hospital discharge system, could improve this estimate but its positive predictive value and sensibility should be evaluated...
Prognostic value of morphology and hormone receptor status in breast cancer - a population-based studyC Allemani
Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milano, Italy
Br J Cancer 91:1263-8. 2004..Morphology and hormone receptor status were confirmed as significant survival predictors in this population-based study, even after adjusting for age and stage at diagnosis...
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)N Bossard
Hospices Civils de Lyon, Service de Biostatistique, Lyon, F 69003, France
Eur J Cancer 43:149-60. 2007..For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis...
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United StatesMilena Sant
Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I 20133, Milan, Italy
Eur J Cancer 44:579-87. 2008..Interpretation of marked variation in survival with morphology is complicated by classification inconsistencies. The completeness and standardisation of cancer registry morphology data needs to be improved...
Cancer incidence and mortality in France over the period 1980-2005A Belot
Service de Biostatistique, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France
Rev Epidemiol Sante Publique 56:159-75. 2008..The objective of this study was to provide updated estimates of national trends in cancer incidence and mortality for France for 1980-2005...
Survival in patients with uveal melanoma in EuropeGianni Virgili
Department of Oto Neuro Ophthalmological Surgical Sciences, University of Florence, Viale Morgagni 85, Florence 50134, Italy
Arch Ophthalmol 126:1413-8. 2008..To estimate survival in patients in whom uveal melanoma was diagnosed between January 1, 1983, and December 31, 1994, in Europe...
Thyroid cancers in France and the Chernobyl accident: risk assessment and recommendations for improving epidemiological knowledgeP Verger
, 23 rue Stanislas Torrents, 13006 Marseille, France
Health Phys 85:323-9. 2003..The surveillance of thyroid cancers in France should be enhanced...
Association of LILRA2 (ILT1, LIR7) splice site polymorphism with systemic lupus erythematosus and microscopic polyangiitisK Mamegano
Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Genes Immun 9:214-23. 2008..Flow cytometry indicated that this isoform was expressed on the surface of monocytes. These findings suggested that LILRA2 Delta 419-421 isoform encoded by the splice site SNP may play a role in SLE and MPA...
The influence of socio-economic and surveillance characteristics on breast cancer survival: a French population-based studyJ Gentil-Brevet
Registre des Cancers du Sein et autres Cancers Gynécologiques de Côte d Or, Centre Georges Francois Leclerc, 1 rue du Professeur Marion BP 77980, Dijon Cedex 21079, France
Br J Cancer 98:217-24. 2008..Socio-economic and surveillance characteristics are independent prognostic factors of both breast cancer stage at diagnosis and of survival. Screening mammography is an independent prognostic factor of survival...
Are there regional differences in the management of colon cancer in France?J M Phelip
Côte d Or and Saône et Loire Cancer Registry, CRI INSERM 95 05 et DRED 1789 Faculté de médecine, 7 Boulevard Jeanne d Arc, 21000 Dijon, France
Eur J Cancer Prev 14:31-7. 2005..001) and in 79.6% of the cases in stage III (in which it is recommended) with extremes from 63.6 to 94.4% (P=0.08). In conclusion, these results should alert practitioners and health care authorities in order to homogenize practices...
Site and clinical outcome of deep vein thrombosis of the lower limbs: an epidemiological studyC Seinturier
Département Pluridisciplinaire de Médecine, Unité de médecine vasculaire, Grenoble, France
J Thromb Haemost 3:1362-7. 2005..Based on a large series of unselected patients, our results show that the site of the DVT and principally the bilaterality provides important prognostic information that may be used in the setting up of medical strategies...
Cannabis: the next villain on the lung cancer battlefield?C Brambilla
Eur Respir J 31:227-8. 2008
